Literature DB >> 23737540

Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients.

Carsten Lukas1, Madeleine H Sombekke, Barbara Bellenberg, Horst K Hahn, Veronica Popescu, Kerstin Bendfeldt, Ernst W Radue, Achim Gass, Stefan J Borgwardt, Ludwig Kappos, Yvonne Naegelin, Dirk L Knol, Chris H Polman, Jeroen J G Geurts, Frederik Barkhof, Hugo Vrenken.   

Abstract

PURPOSE: To determine whether spinal cord atrophy differs among disease subtypes in multiple sclerosis (MS) and whether it offers diagnostic and clinical correlative information beyond that provided by other magnetic resonance (MR) imaging markers.
MATERIALS AND METHODS: The institutional review board approved the study; all subjects gave written informed consent. Upper cervical cord cross-sectional area (UCCA), brain and spinal cord lesion loads, and brain atrophy were measured in 440 patients with MS (311 with relapsing-remitting [RR] MS, 92 with secondary-progressive [SP] MS, and 37 with primary-progressive [PP] MS) studied in two centers. Disability was scored with the Expanded Disability Status Scale (EDSS), the timed 25-foot walk test (TWT), and the nine-hole peg test. UCCA was compared between groups with the Mann-Whitney U test. Correlations were assessed with the Spearman ρ test. Multivariate associations between UCCA and clinical and other MR imaging parameters, including number of hypointense brain lesions on T1-weighted MR images, presence of diffuse abnormalities, and number of involved segments in the spinal cord, were assessed by using multiple linear regression, adjusted for study center site.
RESULTS: The UCCA in patients with SP MS (median, 79 mm(2); interquartile range, 72.4-84.9 mm(2)) and PP MS (median, 77.3 mm(2); interquartile range, 69-82.5 mm(2)) was significantly smaller (P < .001) than that in patients with RR MS (median, 84 mm(2); interquartile range, 78.7-89.3 mm(2)). UCCA was inversely correlated with EDSS score, TWT, and nine-hole peg test findings (ρ ≤ -0.29, P < .001 for all comparisons). UCCA, number of hypointense brain lesions on T1-weighted MR images, presence of diffuse abnormalities, and number of involved segments in the spinal cord were found to be significant explanatory factors for clinical disability (R(2) = 0.564). The UCCA and the number of hypointense brain lesions on T1-weighted images were the strongest MR imaging parameters for explaining physical disability, as measured with the EDSS.
CONCLUSION: Spinal cord abnormalities have a strong effect on clinical disability in MS. MR imaging-derived UCCA was found to be the most significant spinal cord parameter for explaining EDSS score. RSNA, 2013

Entities:  

Mesh:

Year:  2013        PMID: 23737540     DOI: 10.1148/radiology.13122566

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  42 in total

1.  Improved Lesion Detection by Using Axial T2-Weighted MRI with Full Spinal Cord Coverage in Multiple Sclerosis.

Authors:  S Galler; J-P Stellmann; K L Young; D Kutzner; C Heesen; J Fiehler; S Siemonsen
Journal:  AJNR Am J Neuroradiol       Date:  2016-01-07       Impact factor: 3.825

Review 2.  Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 1-Mechanisms, Efficacy, and Safety.

Authors:  C McNamara; G Sugrue; B Murray; P J MacMahon
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

3.  Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.

Authors:  Biao Xiang; Jie Wen; Anne H Cross; Dmitriy A Yablonskiy
Journal:  J Magn Reson Imaging       Date:  2018-08-29       Impact factor: 4.813

4.  Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS.

Authors:  Yaou Liu; Yunyun Duan; Jing Huang; Zhuoqiong Ren; Zheng Liu; Huiqing Dong; Florian Weiler; Horst K Hahn; Fu-Dong Shi; Helmut Butzkueven; Frederik Barkhof; Kuncheng Li
Journal:  Eur Radiol       Date:  2017-06-30       Impact factor: 5.315

5.  Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.

Authors:  Dominique Eden; Charley Gros; Atef Badji; Sara M Dupont; Benjamin De Leener; Josefina Maranzano; Ren Zhuoquiong; Yaou Liu; Tobias Granberg; Russell Ouellette; Leszek Stawiarz; Jan Hillert; Jason Talbott; Elise Bannier; Anne Kerbrat; Gilles Edan; Pierre Labauge; Virginie Callot; Jean Pelletier; Bertrand Audoin; Henitsoa Rasoanandrianina; Jean-Christophe Brisset; Paola Valsasina; Maria A Rocca; Massimo Filippi; Rohit Bakshi; Shahamat Tauhid; Ferran Prados; Marios Yiannakas; Hugh Kearney; Olga Ciccarelli; Seth A Smith; Constantina Andrada Treaba; Caterina Mainero; Jennifer Lefeuvre; Daniel S Reich; Govind Nair; Timothy M Shepherd; Erik Charlson; Yasuhiko Tachibana; Masaaki Hori; Kouhei Kamiya; Lydia Chougar; Sridar Narayanan; Julien Cohen-Adad
Journal:  Brain       Date:  2019-03-01       Impact factor: 13.501

6.  Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability.

Authors:  Denis A Akkad; Barbara Bellenberg; Sarika Esser; Florian Weiler; Jörg T Epplen; Ralf Gold; Carsten Lukas; Aiden Haghikia
Journal:  Neurogenetics       Date:  2015-01-27       Impact factor: 2.660

Review 7.  Clinical relevance of brain volume measures in multiple sclerosis.

Authors:  Nicola De Stefano; Laura Airas; Nikolaos Grigoriadis; Heinrich P Mattle; Jonathan O'Riordan; Celia Oreja-Guevara; Finn Sellebjerg; Bruno Stankoff; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

Review 8.  Brain MRI atrophy quantification in MS: From methods to clinical application.

Authors:  Maria A Rocca; Marco Battaglini; Ralph H B Benedict; Nicola De Stefano; Jeroen J G Geurts; Roland G Henry; Mark A Horsfield; Mark Jenkinson; Elisabetta Pagani; Massimo Filippi
Journal:  Neurology       Date:  2016-12-16       Impact factor: 9.910

Review 9.  Imaging as an Outcome Measure in Multiple Sclerosis.

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

10.  2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times.

Authors:  Nico Papinutto; Regina Schlaeger; Valentina Panara; Eduardo Caverzasi; Sinyeob Ahn; Kevin J Johnson; Alyssa H Zhu; William A Stern; Gerhard Laub; Stephen L Hauser; Roland G Henry
Journal:  J Magn Reson Imaging       Date:  2014-12-08       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.